Cerebral Pseudoatrophy or Real Atrophy After Therapy in Multiple Sclerosis

被引：19
作者：
Khoury, Samia [1 ]
Bakshi, Rohit [2 ]
机构：
[1] Brigham & Womens Hosp, Ctr Neurol Dis, Dept Neurol, Boston, MA 02115 USA
[2] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Neurol, Boston, MA 02115 USA
来源：
ANNALS OF NEUROLOGY | 2010年 / 68卷 / 06期
关键词：
STEM-CELL TRANSPLANTATION; BRAIN ATROPHY; RELAPSING MS;
D O I：
10.1002/ana.22254
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：778 / 779
页数：2
相关论文
共 13 条
  • [1] The measurement and clinical relevance of brain atrophy in multiple sclerosis
    Bermel, RA
    Bakshi, R
    [J]. LANCET NEUROLOGY, 2006, 5 (02) : 158 - 170
  • [2] Brain atrophy after immunoablation and stem cell transplantation in multiple sclerosis
    Chen, J. T.
    Collins, D. L.
    Atkins, H. L.
    Freedman, M. S.
    Galal, A.
    Arnold, D. L.
    [J]. NEUROLOGY, 2006, 66 (12) : 1935 - 1937
  • [3] Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes
    Dalton, CM
    Chard, DT
    Davies, GR
    Miszkiel, KA
    Altmann, DR
    Fernando, K
    Plant, GT
    Thompson, AJ
    Miller, DH
    [J]. BRAIN, 2004, 127 : 1101 - 1107
  • [4] Brain atrophy and magnetization transfer ratio following methylprednisolone in multiple sclerosis: short-term changes and long-term implications
    Fox, RJ
    Fisher, E
    Tkach, J
    Lee, JC
    Cohen, JA
    Rudick, RA
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2005, 11 (02) : 140 - 145
  • [5] Interferon-β-1b slows progression of atrophy in RRMS -: Three-year follow-up in NAb- and NAb+ patients
    Frank, JA
    Richert, N
    Bash, C
    Stone, L
    Calabresi, PA
    Lewis, B
    Stone, R
    Howard, T
    Mcfarland, HF
    [J]. NEUROLOGY, 2004, 62 (05) : 719 - 725
  • [6] Rate of brain atrophy in relapsing MS decreases during treatment with IFNβ-1a
    Hardmeier, M
    Wagenpfeil, S
    Freitag, P
    Fisher, E
    Rudick, RA
    Kooijmans, M
    Clanet, M
    Radue, EW
    Kappos, L
    [J]. NEUROLOGY, 2005, 64 (02) : 236 - 240
  • [7] Sample size requirements for treatment effects using gray matter, white matter and whole brain volume in relapsing-remitting multiple sclerosis
    Healy, B.
    Valsasina, P.
    Filippi, M.
    Bakshi, R.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2009, 80 (11) : 1218 - 1223
  • [8] Inglese M, 2004, J NEUROL NEUROSUR PS, V75, P643
  • [9] MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS
    Miller, D. H.
    Soon, D.
    Fernando, K. T.
    MacManus, D. G.
    Barker, G. J.
    Yousry, T. A.
    Fisher, E.
    O'Connor, P. W.
    Phillips, J. T.
    Polman, C. H.
    Kappos, L.
    Hutchinson, M.
    Havrdova, E.
    Lublin, F. D.
    Giovannoni, G.
    Wajgt, A.
    Rudick, R.
    Lynn, F.
    Panzara, M. A.
    Sandrock, A. W.
    [J]. NEUROLOGY, 2007, 68 (17) : 1390 - 1401
  • [10] Multislice brain myelin water fractions at 3T in multiple sclerosis
    Oh, Joonmi
    Han, Eric T.
    Lee, Michael C.
    Nelson, Sarah J.
    Pelletier, Daniel
    [J]. JOURNAL OF NEUROIMAGING, 2007, 17 (02) : 156 - 163
12